Complications of Type 2 Diabetes among Aboriginal Canadians: Increasing the Understanding of Prevalence and Risk Factors

Canadian Journal of Diabetes

Volumn 27, Issue 4, 2003, Pages 455-463

  Hanley, Anthony J G ^a,b   Harris, Stewart B ^c   Mamakeesick, Mary ^d   Goodwin, Ken ^d   Fiddler, Edith ^d   Hegele, Robert A ^e   McLaughlin, John R ^a,b   Zinman, Bernard ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d Sandy Lake Health and Diabetes Project   (Canada)

^e ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABORIGINE; ANGINA PECTORIS; ATHEROSCLEROSIS; CANADA; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PREVALENCE; REVIEW; RISK FACTOR;

EID: 0347763860     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Young TK, Reading J, Elias B, et al. Type 2 diabetes mellitus in Canada's First Nations: status of an epidemic in progress. CMAJ. 2000;163:561-566.
2. Chase LA.The trend of diabetes in Saskatchewan, 1905-1934. CMAJ. 1937;36:366-369.
3. Montour LT, Macaulay AC. High prevalence rates of diabetes mellitus and hypertension on a North American Indian reservation [letter]. Can Med Assoc J. 1985; 132:1110, 1112.
4. Evers S, McCracken E, Antone I, et al. The prevalence of diabetes in Indians and Caucasians living in Southwestern Ontario. Can J Public Health. 1987;78:240-243.
5. Young TK, Szathmary EJ, Evers S, et al. Geographical distribution of diabetes among the Native population of Canada: a national survey. Soc Sci Med. 1990; 31:129-139.
6. Brassard P, Robinson E, Lavallee C. Prevalence of diabetes mellitus among the James Bay Cree of northern Quebec. CMAJ. 1993;149:303-307.
7. Pioro MP, Dyck RF, Gillis DC. Diabetes prevalence rates among First Nations adults on Saskatchewan reserves in 1990: comparison by tribal grouping, geography and with non-First Nations people. Can J Public Health. 1996;87:325-328.
8. Fox C, Harris SB, Whalen-Brough E. Diabetes among Native Canadians in Northwestern Ontario: 10 years later. Chronic Dis Can. 1994;15:92-96.
9. Delisle HF, Ékoé J-M. Prevalence of non-insulin-dependent diabetes mellitus and impaired glucose tolerance in two Algonquin communities in Quebec. CMAJ. 1993; 148:41-47.
10. Harris SB, Gittelsohn J, Hanley A, et al. The prevalence of NIDDM and associated risk factors in Native Canadians. Diabetes Care. 1997;20:185-187.
11. Dean HJ, Mundy RL, Moffatt M. Non-insulin-dependent diabetes mellitus in Indian children in Manitoba. CMAJ. 1992;147:52-57.
12. Harris SB, Perkins BA, Whalen-Brough E. Non-insulin-dependent diabetes mellitus among First Nations children. New entity among First Nations people of northwestern Ontario. Can Fam Physician. 1996;42:869-876.
13. Reiber GE, Boyko EJ, Smith DG. Lower extremity foot ulcers and amputations in diabetes. In: Diabetes in America. 2nd ed. Bethesda, MD: National Diabetes Data Group, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995:409-428.
14. Klein R, Klein BEK. Vision disorders in diabetes. In: Diabetes in America. 2nd ed. Bethesda, MD: National Diabetes Data Group, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995:293-338.
15. Nelson RG, Knowler WC, Pettitt DJ, et al. Kidney diseases in diabetes. In: Diabetes in America. 2nd ed. Bethesda, MD: National Diabetes Data Group, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995:349-400.
16. Haffner SM, Lehto S, Rönnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229-234.
17. Andresen EM, Lee JAH, Pecoraro RE, et al. Underreporting of diabetes on death certificates, King County, Washington. Am J Public Health. 1993;83:1021-1024.
18. Zimmet PZ, McCarty DJ, de Courten MP. The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome. J Diabetes Complications. 1997; 11:60-68.
19. Gohdes D. Diabetes in North American Indians and Alaska Natives. In: Diabetes in America. 2nd ed. Bethesda, MD: National Diabetes Data Group, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995:683-701.
20. Robbins DC, Knowler WC, Lee ET, et al. Regional differences in albuminuria among American Indians: an epidemic of renal disease. Kidney Int. 1996;49:557-563.
21. Howard BV, Lee ET, Cowan LD, et al. Rising tide of cardiovascular disease in American Indians. The Strong Heart Study. Circulation. 1999;99:2389-2395.
22. Young TK, McIntyre LL, Dooley J, et al. Epidemiologic features of diabetes mellitus among Indians in northwestern Ontario and northeastern Manitoba. Can Med Assoc J. 1985;132:793-797.
23. Macaulay AC, Montour LT, Adelson N. Prevalence of diabetic and atherosclerotic complications among Mohawk Indians of Kahnawake, PQ. CMAJ. 1988;139:221-224.
24. Montour LT, Macaulay AC, Adelson N. Diabetes mellitus in Mohawks of Kahnawake, PQ: a clinical and epidemiologic description. CMAJ. 1989;141:549-552.
25. Young TK, Kaufert JM, McKenzie JK, et al. Excessive burden of end-stage renal disease among Canadian Indians: a national survey. Am J Public Health. 1989;79:756-758.
26. Ross SA, Fick GH. Vascular complications in diabetic Native Canadians [abstract]. Diabetes. 1990;39(suppl 1):125A.
27. Wilson R, Krefting LH, Sutcliffe P, et al. Incidence and prevalence of end-stage renal disease among Ontario's James Bay Cree. Can J Public Health. 1992;83:143-146.
28. Brassard P, Robinson E, Dumont C. Descriptive epidemiology of non-insulin-dependent diabetes mellitus in the James Bay Cree population of Quebec, Canada. Arctic Med Res. 1993; 52:47-54.
29. Brassard P, Robinson E. Factors associated with glycemia and microvascular complications among James Bay Cree Indian diabetics of Quebec. Arctic Med Res. 1995;54:116-124.
30. Dyck RF, Tan L. Rates and outcomes of diabetic end-stage renal disease among registered Native people in Saskatchewan. CMAJ. 1994;150:203-208.
31. Hegele RA, Harris SB, Hanley AJG, et al. Association between AGTT235 variant and microalbuminuria in Canadian Oji-Cree with type 2 diabetes mellitus. Clin Biochem. 1999;32:201-205.
32. Hegele RA, Harris SB, Zinman B, et al. Increased plasma apolipoprotein B-containing lipoproteins associated with increased urinary albumin within the microalbuminuria range in type 2 diabetes. Clin Biochem. 1999;32:143-148.
33. Maberley DA, King W, Cruess AF, et al. Risk factors for diabetic retinopathy in the Cree of James Bay. Ophthalmic Epidemiol. 2002;9:153-167.
34. Dyck R, Bohm C, Klomp H. Increased frequency of HLA A2/DR4 and A2/DR8 haplotypes in young Saskatchewan Aboriginal people with diabetic end-stage renal disease. Am J Nephrol. 2003;23:178-185.
35. Delisle HF, Rivard M, Ékoé J-M. Prevalence estimates of diabetes and of other cardiovascular risk factors in the two largest Algonquin communities of Quebec. Diabetes Care. 1995;18:1255-1259.
36. Harris SB, Zinman B, Hanley A, et al. The impact of diabetes on cardiovascular risk factors and outcomes in a native Canadian population. Diabetes Res Clin Pract. 2002;55:165-173.
37. Shah BR, Hux JE, Zinman B. Increasing rates of ischemic heart disease in the Native population of Ontario, Canada. Arch Intern Med. 2000;160:1862-1866.
38. Anand SS, Yusuf S, Jacobs R, et al. Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP). Lancet. 2001;358:1147-1153.
39. Bursell S-E, Cavallerano JD, Cavallerano AA, et al., Stereo non-mydriatic digital-video color retinal imaging compared with Early Treatment Diabetic Retinopathy Study seven standard field 35-mm stereo color photos for determining level of diabetic retinopathy. Ophthalmology. 2001;108:572-585.
40. Feldman EL, Stevens MJ, Thomas PK, et al. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care. 1994;17:1281-1289.
41. Parsons MP, Newman DJ, Newall RG, et al. Validation of a point-of-care assay for the urinary albumin: creatinine ratio. Clin Chem. 1999;45:414-417.
42. Bots ML, Hoes AW, Koudstaal PJ, et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997;96:1432-1437.
43. Shinozaki T, Hasegawa T, Yano E. Ankle-arm index as an indicator of atherosclerosis: its application as a screening method. J Clin Epidemiol. 1998;51:1263-1269.
44. Sorlie PD, Cooper L, Schreiner PJ, et al. Repeatability and validity of the Rose questionnaire for angina pectoris in the Atherosclerosis Risk in Communities Study. J Clin Epidemiol. 1996;49:719-725.
45. John WG, Edwards R, Price CP. Laboratory evaluation of the DCA 2000 clinic HbA1c immunoassay analyser. Ann Clin Biochem. 1994;31:367-370.
46. Joannou J, Kalk WJ, Mahomed I, et al. Screening for diabetic retinopathy in South Africa with 60 degrees retinal colour photography. J Intern Med. 1996;239:43-47.
47. Penman AD, Saaddine JB, Hegazy M, et al. Screening for diabetic retinopathy: the utility of nonmydriatic retinal photography in Egyptian adults. Diabet Med. 1998;15:783-787.
48. Liesenfeld B, Kohner E, Piehlmeier W, et al. A telemedical approach to the screening of diabetic retinopathy: digital fundus photography. Diabetes Care. 2000;23:345-348.
49. NORTH Network. Available at: http://www.northnetwork. com. Accessed September 19, 2003.
50. Meltzer S, Leiter L, Daneman D, et al. 1998 clinical practice guidelines for the management of diabetes in Canada. CMAJ. 1998;159(suppl 8):S1-S29.
51. Spence JD, Malinow MR, Barnett PA, et al. Plasma homocyst(e)ine concentration, but not MTHFR genotype, is associated with variation in carotid plaque area. Stroke. 1999; 30:969-973.
52. Spence JD, Eliasziw M, DiCicco M, et al. Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy. Stroke. 2002;33:2916-2922.
53. Kuller LH. Is ankle-brachial blood pressure measurement of clinical utility for asymptomatic elderly? J Clin Epidemiol. 2001;54:971-972.
54. Rose GA, Blackburn H. Cardiovascular Survey Methods, Monograph Series No. 56. Geneva, Switzerland: World Health Organization; 1968.
55. Hanley AJG, Harris SB, Barnie A, et al. The Sandy Lake Health and Diabetes Project: design, methods and lessons learned. Chronic Dis Can. 1995;16:149-156.